• About
    • Our Team
    • Clinical Advisory Board
    • Board of Directors
  • Product
  • Investors & Partners
  • News
  • Contact

News

Zucara Therapeutics Announces US$21 Million Series A Financing

March 31, 2020 by zucaraadmin

Zucara Therapeutics Announces US$21 Million Series A Financing – Proceeds to Fund Development of ZT-01 Through Phase 2 Clinical Trials

read more

Zucara Therapeutics Presents New Data at European Association for the Study of Diabetes

September 19, 2019 by zucaraadmin

Dr. Richard Liggins, Chief Scientific Officer, presenting at EASD in Barcelona. TORONTO, Canada and BARCELONA, Spain: Zucara Therapeutics Inc., a

read more

Zucara Therapeutics Secures Grant from GlycoNet to Expand and Validate their Drug Therapy Model for Type 1 Diabetes to Type 2 Diabetes

July 12, 2019 by zucaraadmin

Toronto & Vancouver, Canada:  Zucara Therapeutics Inc., a life sciences company developing the first once-daily therapeutic to prevent hypoglycemia in

read more

Remembering Dr. Mladen Vranic: The Outstanding Diabetes Researcher

June 24, 2019 by zucaraadmin

(Michael Midmer & Dr. Mladen Vranic) Dr. Mladen Vranic, a leading scientist and advocate for the advancement of diabetes research,

read more

Zucara Therapeutics Adds Additional Drug Development Executives to its Board of Directors

May 14, 2019 by zucaraadmin

TORONTO, Canada: Zucara Therapeutics Inc., a life sciences company developing the first once-daily therapeutic to prevent hypoglycemia in people with

read more

Susan Peers Joins Zucara’s Leadership Team

March 13, 2019 by zucaraadmin

Zucara Therapeutics Inc., a life sciences company developing the first once-daily therapeutic to prevent hypoglycemia in people with Type 1

read more

Zucara Therapeutics – Helping people with diabetes sleep safely and soundly

November 14, 2018 by zucaraadmin

Typically occurring overnight, hypoglycemia puts over 8 million people with diabetes at fatal risk during their sleep. Current therapies offer

read more

Zucara Therapeutics Secures US$3.9M from the Helmsley Charitable Trust to Advance Diabetes Drug Candidate to Clinical Trials

April 9, 2018 by zucaraadmin

Toronto and Vancouver, Canada: Zucara Therapeutics Inc., a diabetes life sciences company advancing the first once-daily therapeutic to prevent low blood

read more

Zucara Therapeutics Receives Funding to Advance Lead Drug Candidate

February 8, 2018 by zucaraadmin

VANCOUVER and TORONTO, Canada — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to

read more

Zucara Confirmed to Present at Biotech Showcase 2018

December 12, 2017 by zucaraadmin

Michael Midmer, CEO of Zucara Therapeutics, is confirmed to present at the 10th Annual Biotech Showcase. This important investor and

read more
  • «Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page»

OUR PARTNERS





CATEGORIES

  • News

Copyright 2023 Zucara Therapeutics, all rights reserved.